CC BY-NC-ND 4.0 · Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery 2023; 42(02): e89-e100
DOI: 10.1055/s-0043-1769777
Original Article | Artigo Original

Endoscopic Transsphenoidal Surgery of Pituitary Adenomas: Preliminary Results of the Neurosurgery Service of Hospital Cristo Redentor

Cirurgia endoscópica transesfenoidal de adenomas pituitários: resultados preliminares do Serviço de Neurocirurgia do Hospital Cristo Redentor
1   Department of Neurosurgery, Neurosurgery Service, Hospital Cristo Redentor, Porto Alegre, RS, Brazil
,
Afonso Mariante
2   Department of Otolaryngology, Hospital Nossa Senhora da Conceição, Porto Alegre, RS, Brazil
,
Fernando Azambuja
3   Department of Endocrinology and Metabolism, Hospital Nossa Senhora da Conceição, Porto Alegre, RS, Brazil
,
1   Department of Neurosurgery, Neurosurgery Service, Hospital Cristo Redentor, Porto Alegre, RS, Brazil
,
1   Department of Neurosurgery, Neurosurgery Service, Hospital Cristo Redentor, Porto Alegre, RS, Brazil
,
Giulia Pinzetta
4   Department of Internal Medicine, School of Medicine, Universidade do Vale do Rio dos Sinos, São Leopoldo, RS, Brazil
› Author Affiliations

Abstract

Objective The transsphenoidal surgery is a safe and effective technique to manage different skull base pathologies, such as pituitary adenomas. The purpose of the present study is to describe the initial experience with endoscopic transsphenoidal surgery in the treatment of pituitary adenoma patients at a tertiary hospital that is a reference in neurosurgery in Southern Brazil.

Materials and Methods We retrospectively analyzed data from 60 patients with pituitary adenoma who underwent endoscopic transsphenoidal surgery between 2012 and 2019. Demographic characteristics, type of tumor, baseline hormonal changes, and clinical presentation were reported, as well as postoperative outcomes, tumor resection rate, and complications.

Results The male/female ratio was of 0.53:1, and the mean age of the sample was of 54 (range: 26 to 79) years. In total, 34 patients (57%) presented the non-functioning adenoma subtype, and 26 (43%), the functioning adenoma subtype. In the non-functioning and functioning subtype groups, the average tumor diameter was of 32 mm and 18 mm, and the mean follow-up was of 27 months and 32 months respectively. Regarding visual symptoms, 79% of the patients showed improvement after surgery. Hormonal remission was achieved in 71% of the patients with prolactinoma, 85% of those with cushing, and 57% of patients with acromegaly. Overall, gross total resection (GTR) was achieved in 50% of patients but with a significantly lower rate among patients with tumors with parasellar growth (high grade on the Knosp classification). The most prevalent surgical complications observed were postoperative cerebrospinal fluid (CSF) leak and meningitis in 11% and 6% of the cases respectively.

Conclusion We have shown that transsphenoidal endoscopic surgery can produce good results in the management of pituitary adenomas, with acceptable peri- and postoperative morbidity and mortality. Regardless of the technique used, the presence of large and giant pituitary adenomas with a high Knosp grade represents an enormous challenge for contemporary neurosurgery.

Resumo

Objetivo A cirurgia transesfenoidal é uma técnica segura e eficaz para o tratamento de patologias da base do crânio, como os adenomas hipofisários. O objetivo deste estudo é demonstrar a experiência inicial com a cirurgia endoscópica transesfenoidal no tratamento de pacientes com adenoma hipofisário em hospital terciário, referência em neurocirurgia no Sul do Brasil.

Materiais e Métodos Analisamos retrospectivamente os dados de 60 pacientes com adenoma hipofisário submetidos à cirurgia endoscópica transesfenoidal entre 2012 e 2019. Características demográficas, tipo de tumor, alterações hormonais basais e apresentação clínica foram relatadas, bem como evolução pós-operatória, grau de ressecção tumoral e complicações.

Resultados A proporção homem/mulher foi de 0.53:1, e a idade média da amostra foi de 54 (variação: 26 a 79) anos. Ao todo, 34 pacientes (57%) tinham o subtipo funcional de adenoma, e 26 (43%), o subtipo não funcional de adenoma. Nos grupos não funcional e funcional, o diâmetro médio do tumor foi de 32 mm e 18 mm, e o tempo médio de acompanhamento foi de 27 meses e 32 meses, respectivamente. Em relação aos sintomas visuais, 79% dos pacientes apresentaram melhora após a cirurgia. A remissão hormonal foi alcançada em 71% dos pacientes com adenomas secretores de prolactina, em 85% daqueles com adenomas secretores de hormônio adrenocorticotrófico e em 57% dos pacientes com adenomas secretores de hormônio do crescimento. A ressecção total foi obtida em 50% dos pacientes, mas com taxa significativamente menor em pacientes com tumores com crescimento parasselar (grau elevado na classificação de Knosp). As complicações cirúrgicas mais prevalentes observadas foram fístula liquórica pós-operatória e meningite, em 11% e 6% dos casos, respectivamente.

Conclusão Demostramos que a cirurgia endoscópica transesfenoidal pode produzir bons resultados no manejo de adenomas hipofisários, com aceitável morbimortalidade peri e pós-operatória. Independentemente da técnica utilizada, a presença de adenomas hipofisários grandes e gigantes com grau de Knosp elevado representa um enorme desafio para a neurocirurgia contemporânea.



Publication History

Received: 10 November 2021

Accepted: 24 January 2023

Article published online:
28 June 2023

© 2023. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Liu JK, Das K, Weiss MH, Laws Jr ER, Couldwell WT. The history and evolution of transsphenoidal surgery. J Neurosurg 2001; 95 (06) 1083-1096
  • 2 Prevedello DM, Doglietto F, Jane Jr JAJ, Jagannathan J, Han J, Laws Jr ERJ. History of endoscopic skull base surgery: its evolution and current reality. J Neurosurg 2007; 107 (01) 206-213
  • 3 Grosvenor AE, Laws ER. The evolution of extracranial approaches to the pituitary and anterior skull base. Pituitary 2008; 11 (04) 337-345
  • 4 Artico M, Pastore FS, Fraioli B, Giuffrè R. The contribution of Davide Giordano (1864-1954) to pituitary surgery: the transglabellar-nasal approach. Neurosurgery 1998; 42 (04) 909-911 , discussion 911–912 DOI: 10.1097/00006123-199804000-00121.
  • 5 Kanter AS, Dumont AS, Asthagiri AR, Oskouian RJ, Jane Jr JA, Laws Jr ER. The transsphenoidal approach. A historical perspective. Neurosurg Focus 2005; 18 (04) e6
  • 6 Liu JK, Cohen-Gadol AA, Laws Jr ERJ, Cole CD, Kan P, Couldwell WT. Harvey Cushing and Oskar Hirsch: early forefathers of modern transsphenoidal surgery. J Neurosurg 2005; 103 (06) 1096-1104
  • 7 Lanzino G, Laws Jr ERJ. Pioneers in the development of transsphenoidal surgery: Theodor Kocher, Oskar Hirsch, and Norman Dott. J Neurosurg 2001; 95 (06) 1097-1103
  • 8 Rosegay H. Cushing's legacy to transsphenoidal surgery. J Neurosurg 1981; 54 (04) 448-454
  • 9 Meyer C, Ritter F. Tumor de Hipófise: Operação de Hirsch-Segura. - Estudo neuro-clínico e oftalmologico. Rev dos Cursos. Fac Med. 1935; 21 (21) 1-23
  • 10 Hardy J. Transphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg 1969; 16: 185-217
  • 11 Hardy J. Transsphenoidal hypophysectomy. J Neurosurg 1971; 34 (04) 582-594
  • 12 Cavallo LM, Messina A, Cappabianca P. et al. Endoscopic endonasal surgery of the midline skull base: anatomical study and clinical considerations. Neurosurg Focus 2005; 19 (01) E2
  • 13 Castelnuovo P, Dallan I, Battaglia P, Bignami M. Endoscopic endonasal skull base surgery: past, present and future. Eur Arch Otorhinolaryngol 2010; 267 (05) 649-663
  • 14 Doglietto F, Prevedello DM, Jane Jr JAJ, Han J, Laws Jr ERJ. Brief history of endoscopic transsphenoidal surgery–from Philipp Bozzini to the First World Congress of Endoscopic Skull Base Surgery. Neurosurg Focus 2005; 19 (06) E3
  • 15 Jankowski R, Auque J, Simon C, Marchal JC, Hepner H, Wayoff M. Endoscopic pituitary tumor surgery. Laryngoscope 1992; 102 (02) 198-202
  • 16 Sethi DS, Pillay PK. Endoscopic management of lesions of the sella turcica. J Laryngol Otol 1995; 109 (10) 956-962
  • 17 Jho H-D, Carrau RL. Endoscopic endonasal transsphenoidal surgery: experience with 50 patients. J Neurosurg 1997; 87 (01) 44-51 https://thejns.org/view/journals/j-neurosurg/87/1/article-p44.xml
  • 18 Cappabianca P, Alfieri A, de Divitiis E. Endoscopic endonasal transsphenoidal approach to the sella: towards functional endoscopic pituitary surgery (FEPS). Minim Invasive Neurosurg 1998; 41 (02) 66-73 10.1055/s-2008-1052019
  • 19 Alfieri A, Jho H-D, Tschabitscher M. Endoscopic endonasal approach to the ventral cranio-cervical junction: anatomical study. Acta Neurochir (Wien) 2002; 144 (03) 219-225 , discussion 225 http://www.ncbi.nlm.nih.gov/pubmed/11956934
  • 20 Cappabianca P, Frank G, Pasquini E, de Divitiis O, Calbucci F. Extended endoscopic endonasal transsphenoidal approaches to the suprasellar region, planum sphenoidale and clivus. In: de Divitiis E, Cappabianca P. eds. Endoscopic Endonasal Transsphenoidal Surgery [Internet]. Vienna: Springer Vienna; 2003: 176-187 . Available from: https://doi.org/10.1007/978-3-7091-6084-8_11
  • 21 Solari D, Morace R, Cavallo LM. et al. The endoscopic endonasal approach for the management of craniopharyngiomas. J Neurosurg Sci 2016; 60 (04) 454-462
  • 22 Linsler S, Oertel J. Endoscopic Endonasal Transclival Resection of a Brainstem Cavernoma: A Detailed Account of Our Technique and Comparison with the Literature. World Neurosurg 2015; 84 (06) 2064-2071
  • 23 Kassam AB, Gardner P, Snyderman C, Mintz A, Carrau R. Expanded endonasal approach: fully endoscopic, completely transnasal approach to the middle third of the clivus, petrous bone, middle cranial fossa, and infratemporal fossa. Neurosurg Focus 2005; 19 (01) E6
  • 24 Frank G, Pasquini E, Doglietto F. et al. The endoscopic extended transsphenoidal approach for craniopharyngiomas. Neurosurgery 2006; 59 (1, Suppl 1) ONS75-ONS83 , discussion ONS75–ONS83
  • 25 Snyderman C, Kassam A, Carrau R, Mintz A. Endoscopic approaches to the petrous apex. Oper Tech Otolaryngol Neck Surg. 2006; 17: 168-173
  • 26 Fernandez-Miranda JC, Gardner PA, Prevedello DM, Kassam AB. Expanded endonasal approach for olfactory groove meningioma. Acta Neurochir (Wien) 2009; 151 (03) 287-288 , author reply 289–290
  • 27 Dehdashti AR, Ganna A, Witterick I, Gentili F. Expanded endoscopic endonasal approach for anterior cranial base and suprasellar lesions: indications and limitations. Neurosurgery 2009; 64 (04) 677-687 , discussion 687–689
  • 28 Shin M, Kondo K, Saito N. Current Status of Endoscopic Endonasal Surgery for Skull Base Meningiomas: Review of the Literature. Neurol Med Chir (Tokyo) 2015; 55 (09) 735-743 https://pubmed.ncbi.nlm.nih.gov/26345667
  • 29 Mangussi-Gomes J, Beer-Furlan A, Balsalobre L, Vellutini EAS, Stamm AC. Endoscopic Endonasal Management of Skull Base Chordomas: Surgical Technique, Nuances, and Pitfalls. Otolaryngol Clin North Am 2016; 49 (01) 167-182
  • 30 Zoli M, Milanese L, Bonfatti R. et al. Clival chordomas: considerations after 16 years of endoscopic endonasal surgery. J Neurosurg 2018; 128 (02) 329-338
  • 31 Hammer G, Rådberg C. The sphenoidal sinus. An anatomical and roentgenologic study with reference to transsphenoid hypophysectomy. Acta Radiol 1961; 56 (06) 401-422 https://journals.sagepub.com/doi/abs/10.1177/028418516105600601
  • 32 Hardy J, Vezina JL. Transsphenoidal neurosurgery of intracranial neoplasm. Adv Neurol 1976; 15: 261-273
  • 33 Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 1993; 33 (04) 610-617 , discussion 617–618
  • 34 Li H-Y, Feng C-Y, Zhang C. et al. Microscopic surgery for pituitary adenomas to preserve the pituitary gland and stalk. Exp Ther Med 2017; 13 (03) 1011-1016
  • 35 Gandhi CD, Christiano LD, Eloy JA, Prestigiacomo CJ, Post KD. The historical evolution of transsphenoidal surgery: facilitation by technological advances. Neurosurg Focus 2009; 27 (03) E8
  • 36 Theodros D, Patel M, Ruzevick J, Lim M, Bettegowda C. Pituitary adenomas: historical perspective, surgical management and future directions. CNS Oncol 2015; 4 (06) 411-429
  • 37 Yu S-Y, Du Q, Yao S-Y. et al. Outcomes of endoscopic and microscopic transsphenoidal surgery on non-functioning pituitary adenomas: a systematic review and meta-analysis. J Cell Mol Med 2018; 22 (03) 2023-2027 https://pubmed.ncbi.nlm.nih.gov/29314715
  • 38 White DR, Sonnenburg RE, Ewend MG, Senior BA. Safety of minimally invasive pituitary surgery (MIPS) compared with a traditional approach. Laryngoscope 2004; 114 (11) 1945-1948
  • 39 Nishioka H. Recent Evolution of Endoscopic Endonasal Surgery for Treatment of Pituitary Adenomas. Neurol Med Chir (Tokyo) 2017; 57 (04) 151-158 https://pubmed.ncbi.nlm.nih.gov/28239067
  • 40 O'Malley Jr BWJ, Grady MS, Gabel BC. et al. Comparison of endoscopic and microscopic removal of pituitary adenomas: single-surgeon experience and the learning curve. Neurosurg Focus 2008; 25 (06) E10
  • 41 Cappabianca P, Cavallo LM, Solari D, Stagno V, Esposito F, de Angelis M. Endoscopic endonasal surgery for pituitary adenomas. World Neurosurg 2014; 82 (06) S3-S11
  • 42 Tabaee A, Anand VK, Barrón Y. et al. Predictors of short-term outcomes following endoscopic pituitary surgery. Clin Neurol Neurosurg 2009; 111 (02) 119-122
  • 43 Jain AK, Gupta AK, Pathak A, Bhansali A, Bapuraj JR. Endonasal transsphenoidal pituitary surgery: is tumor volume a key factor in determining outcome?. Am J Otolaryngol 2008; 29 (01) 48-50
  • 44 Esposito D, Olsson DS, Ragnarsson O, Buchfelder M, Skoglund T, Johannsson G. Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management. Pituitary 2019; 22 (04) 422-434
  • 45 Penn DL, Burke WT, Laws ER. Management of non-functioning pituitary adenomas: surgery. Pituitary 2018; 21 (02) 145-153
  • 46 Dekkers OM, Pereira AM, Roelfsema F. et al. Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 2006; 91 (05) 1796-1801
  • 47 Wichers-Rother M, Hoven S, Kristof RA, Bliesener N, Stoffel-Wagner B. Non-functioning pituitary adenomas: endocrinological and clinical outcome after transsphenoidal and transcranial surgery. Exp Clin Endocrinol Diabetes 2004; 112 (06) 323-327
  • 48 Murad MH, Fernández-Balsells MM, Barwise A. et al. Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 2010; 73 (06) 777-791
  • 49 Wang F, Zhou T, Wei S. et al. Endoscopic endonasal transsphenoidal surgery of 1,166 pituitary adenomas. Surg Endosc 2015; 29 (06) 1270-1280
  • 50 Gondim JA, Schops M, de Almeida JPC. et al. Endoscopic endonasal transsphenoidal surgery: surgical results of 228 pituitary adenomas treated in a pituitary center. Pituitary 2010; 13 (01) 68-77
  • 51 Cappabianca P, Cavallo LM, de Divitiis E. Endoscopic endonasal transsphenoidal surgery. Neurosurgery 2004; 55 (04) 933-940 , discussion 940–941
  • 52 Kim JH, Lee JH, Lee JH, Hong AR, Kim YJ, Kim YH. Endoscopic Transsphenoidal Surgery Outcomes in 331 Nonfunctioning Pituitary Adenoma Cases After a Single Surgeon Learning Curve. World Neurosurg 2018; 109: e409-e416
  • 53 Torales J, Halperin I, Hanzu F. et al. Endoscopic endonasal surgery for pituitary tumors. Results in a series of 121 patients operated at the same center and by the same neurosurgeon. Endocrinol Nutr 2014; 61 (08) 410-416
  • 54 Dehdashti AR, Ganna A, Karabatsou K, Gentili F. Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery 2008; 62 (05) 1006-1015 , discussion 1015–1017
  • 55 Bokhari AR, Davies MA, Diamond T. Endoscopic transsphenoidal pituitary surgery: a single surgeon experience and the learning curve. Br J Neurosurg 2013; 27 (01) 44-49
  • 56 Ciric I, Ragin A, Baumgartner C, Pierce D. Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 1997; 40 (02) 225-236 , discussion 236–237
  • 57 Micko ASG, Wöhrer A, Wolfsberger S, Knosp E. Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J Neurosurg 2015; 122 (04) 803-811
  • 58 Maletkovic J, Dabbagh A, Zhang D. et al. Residual Tumor Confers a 10-Fold Increased Risk of Regrowth in Clinically Nonfunctioning Pituitary Tumors. J Endocr Soc 2019; 3 (10) 1931-1941
  • 59 Roelfsema F, Biermasz NR, Pereira AM. Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 2012; 15 (01) 71-83 https://pubmed.ncbi.nlm.nih.gov/21918830
  • 60 Almeida JP, Ruiz-Treviño AS, Liang B. et al. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature. J Neurosurg 2018; 129 (02) 404-416
  • 61 Nomikos P, Buchfelder M, Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’. Eur J Endocrinol 2005; 152 (03) 379-387
  • 62 Han Y-L, Chen D-M, Zhang C, Pan M, Yang X-P, Wu Y-G. Retrospective analysis of 52 patients with prolactinomas following endoscopic endonasal transsphenoidal surgery. Medicine (Baltimore) 2018; 97 (45) e13198-e13198 https://pubmed.ncbi.nlm.nih.gov/30407358
  • 63 Zielinski G, Ozdarski M, Maksymowicz M, Szamotulska K, Witek P. Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery. Front Endocrinol (Lausanne) 2020; 11: 439
  • 64 Donoho DA, Laws Jr ER. The Role of Surgery in the Management of Prolactinomas. Neurosurg Clin N Am 2019; 30 (04) 509-514 DOI: 10.1016/j.nec.2019.05.010.
  • 65 Akinduro OO, Lu VM, Izzo A. et al. Radiographic and Hormonal Regression in Prolactinomas: An Analysis of Treatment Failure. World Neurosurg 2019; 129: e686-e694
  • 66 Ferriere A, Tabarin A. Cushing's syndrome: Treatment and new therapeutic approaches. Best Pract Res Clin Endocrinol Metab 2020; 34 (02) 101381
  • 67 Patil CG, Prevedello DM, Lad SP. et al. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery. J Clin Endocrinol Metab 2008; 93 (02) 358-362 DOI: 10.1210/jc.2007-2013.
  • 68 Pivonello R, De Leo M, Cozzolino A, Colao A. The Treatment of Cushing's Disease. Endocr Rev 2015; 36 (04) 385-486 https://pubmed.ncbi.nlm.nih.gov/26067718
  • 69 Braun LT, Rubinstein G, Zopp S. et al. Recurrence after pituitary surgery in adult Cushing's disease: a systematic review on diagnosis and treatment. Endocrine 2020; 70 (02) 218-231 DOI: 10.1007/s12020-020-02432-z.
  • 70 Johnston PC, Hamrahian AH, Prayson RA, Kennedy L, Weil RJ. Thyrotoxicosis with absence of clinical features of acromegaly in a TSH- and GH-secreting, invasive pituitary macroadenoma. Endocrinol Diabetes Metab Case Rep 2015; 2015: 140070
  • 71 Lee EY, Ku CR, Kim HM. et al. A Case of Pituitary Adenoma with Simultaneous Secretion of TSH and GH. Endocrinol Metab (Seoul) 2011; 26 (02) 160-165 DOI: 10.3803/EnM.2011.26.2.160.
  • 72 Berker D, Isik S, Aydin Y. et al. Thyrotropin secreting pituitary adenoma accompanying a silent somatotropinoma. Turk Neurosurg 2011; 21 (03) 403-407
  • 73 Qureshi T, Chaus F, Fogg L, Dasgupta M, Straus D, Byrne RW. Learning curve for the transsphenoidal endoscopic endonasal approach to pituitary tumors. Br J Neurosurg 2016; 30 (06) 637-642
  • 74 Thawani JP, Ramayya AG, Pisapia JM, Abdullah KG, Lee JY-K, Grady MS. Operative Strategies to Minimize Complications Following Resection of Pituitary Macroadenomas. J Neurol Surg B Skull Base 2017; 78 (02) 184-190 https://pubmed.ncbi.nlm.nih.gov/28321384
  • 75 Lobatto DJ, de Vries F, Zamanipoor Najafabadi AH. et al. Preoperative risk factors for postoperative complications in endoscopic pituitary surgery: a systematic review. Pituitary 2018; 21 (01) 84-97
  • 76 Boling CC, Karnezis TT, Baker AB. et al. Multi-institutional study of risk factors for perioperative morbidity following transnasal endoscopic pituitary adenoma surgery. Int Forum Allergy Rhinol 2016; 6 (01) 101-107
  • 77 Zhang L, Chen M. Analysis of factors causing intracranial infection after endoscopic resection of pituitary tumors by transnasal-sphenoidal approach. Biomed Res 2014; 25 (04) 437-440
  • 78 Komotar RJ, Starke RM, Raper DMS, Anand VK, Schwartz TH. Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of giant pituitary adenomas. Pituitary 2012; 15 (02) 150-159
  • 79 de Paiva Neto MA, Vandergrift A, Fatemi N. et al. Endonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas. Clin Endocrinol (Oxf) 2010; 72 (04) 512-519
  • 80 Yano S, Hide T, Shinojima N. Efficacy and Complications of Endoscopic Skull Base Surgery for Giant Pituitary Adenomas. World Neurosurg 2017; 99: 533-542
  • 81 Chowdhury T, Prabhakar H, Bithal PK, Schaller B, Dash HH. Immediate postoperative complications in transsphenoidal pituitary surgery: A prospective study. Saudi J Anaesth 2014; 8 (03) 335-341 https://pubmed.ncbi.nlm.nih.gov/25191182
  • 82 Olson DR, Guiot G, Derome P. The symptomatic empty sella. Prevention and correction via the transsphenoidal approach. J Neurosurg 1972; 37 (05) 533-537
  • 83 Thomé C, Zevgaridis D. Delayed visual deterioration after pituitary surgery–a review introducing the concept of vascular compression of the optic pathways. Acta Neurochir (Wien) 2004; 146 (10) 1131-1135 , discussion 1135–1136
  • 84 Barzaghi LR, Donofrio CA, Panni P, Losa M, Mortini P. Treatment of empty sella associated with visual impairment: a systematic review of chiasmapexy techniques. Pituitary 2018; 21 (01) 98-106
  • 85 Chen X, Huang W, Li H. et al. Comparison of outcomes between endoscopic and microscopic transsphenoidal surgery for the treatment of pituitary adenoma: a meta-analysis. Gland Surg 2020; 9 (06) 2162-2174 https://pubmed.ncbi.nlm.nih.gov/33447567